Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci. 1989;12:366–75.
Article
CAS
PubMed
Google Scholar
Alkemade A, de Hollander G, Keuken MC, Schäfer A, Ott DV, Schwarz J, Weise D, Kotz SA, Forstmann BU. Comparison of T2*-weighted and QSM contrasts in Parkinson's disease to visualize the STN with MRI. PLoS One. 2017;12:e0176130.
Article
PubMed
PubMed Central
CAS
Google Scholar
Aymerich MS, Barroso-Chinea P, Perez-Manso M, Munoz-Patino AM, Moreno-Igoa M, Gonzalez-Hernandez T, Lanciego JL. Consequences of unilateral nigrostriatal denervation on the thalamostriatal pathway in rats. Eur J Neurosci. 2006;23:2099–108.
Article
CAS
PubMed
Google Scholar
Ayton S, Lei P. Nigral iron elevation is an invariable feature of Parkinson’s disease and is a sufficient cause of neurodegeneration. BioMed Res Int. 2014;2014:581256. https://doi.org/10.1155/2014/581256.
Article
CAS
Google Scholar
Bilgic B, Pfefferbaum A, Rohlfing T, Sullivan EV, Adalsteinsson E. MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping. Neuroimage. 2012;59:2625–35.
Article
CAS
PubMed
Google Scholar
Blesa J, Juri C, Collantes M, Peñuelas I, Prieto E, Iglesias E, Martí-Climent J, Arbizu J, Zubieta JL, Rodríguez-Oroz MC. Progression of dopaminergic depletion in a model of MPTP-induced parkinsonism in non-human primates. An 18F-DOPA and 11C-DTBZ PET study. Neurobiol Dis. 2010;38:456–63.
Article
CAS
PubMed
Google Scholar
Blesa J, Pifl C, Sanchez-Gonzalez MA, Juri C, Garcia-Cabezas MA, Adanez R, Iglesias E, Collantes M, Penuelas I, Sanchez-Hernandez JJ, Rodriguez-Oroz MC, Avendano C, Hornykiewicz O, Cavada C, Obeso JA. The nigrostriatal system in the presymptomatic and symptomatic stages in the MPTP monkey model: a PET, histological and biochemical study. Neurobiol Dis. 2012;48:79–91.
Article
CAS
PubMed
Google Scholar
Brooks D, Halliday GM. Intralaminar nuclei of the thalamus in Lewy body diseases. Brain Res Bull. 2009;78:97–104.
Article
PubMed
Google Scholar
Cass WA, Grondin R, Andersen AH, Zhang Z, Hardy PA, Hussey-Andersen LK, Rayens WS, Gerhardt GA, Gash DM. Iron accumulation in the striatum predicts aging-related decline in motor function in rhesus monkeys. Neurobiol Aging. 2007;28:258–71.
Article
CAS
PubMed
Google Scholar
DeLong MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 1990;13:281–5.
Article
CAS
PubMed
Google Scholar
Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin J-C, Pujol S, Bauer C, Jennings D, Fennessy F, Sonka M. 3D slicer as an image computing platform for the quantitative imaging network. Magn Reson Imag. 2012;30:1323–41.
Article
Google Scholar
Garg A, Appel-Cresswell S, Popuri K, McKeown MJ, Beg MF. Morphological alterations in the caudate, putamen, pallidum, and thalamus in Parkinson’s disease. Front Neurosci. 2015;9:101.
Article
PubMed
PubMed Central
Google Scholar
George, K., Das, J. M (2019) Neuroanatomy, Thalamocortical Radiations. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK546699/. Accessed 05 Dec 2019.
Guan X, Xuan M, Gu Q, Huang P, Liu C, Wang N, Xu X, Luo W, Zhang M. Regionally progressive accumulation of iron in Parkinson’s disease as measured by quantitative susceptibility mapping. NMR Biomed. 2017;30(4):e3489.
Article
CAS
Google Scholar
Haacke EM, Liu S, Buch S, Zheng W, Wu D, Ye Y. Quantitative susceptibility mapping: current status and future directions. Magn Reson Imaging. 2015;33:1–25.
Article
PubMed
Google Scholar
Halliday GM. Thalamic changes in Parkinson’s disease. Parkinsonism Relat D. 2009;15:S152–5.
Article
Google Scholar
Hodaie M, Neimat JS, Lozano AM. The dopaminergic nigrostriatal system and Parkinson’s disease: molecular events in development, disease, and cell death, and new therapeutic strategies. Neurosurg. 2007;60:17–28.
Article
Google Scholar
Jagmag SA, Tripathi N, Shukla SD, Maiti S, Khurana S. Evaluation of models of Parkinson’s disease. Front Neurosci. 2015;9:503.
PubMed
Google Scholar
Jellinger KA. The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson’s disease. Drugs Aging. 1999;14:115–40.
Article
CAS
PubMed
Google Scholar
Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM. FSL. Neuroimage. 2012;62:782–90.
Article
PubMed
Google Scholar
Jiang H, Wang J, Rogers J, Xie J. Brain Iron metabolism dysfunction in Parkinson’s disease. Mol Neurobiol. 2017;54:3078–101.
Article
CAS
PubMed
Google Scholar
Kazumata K, Dhawan V, Chaly T, Antonini A, Margouleff C, Belakhlef A, Neumeyer J, Eidelberg D. Dopamine transporter imaging with fluorine-18-FPCIT and PET. J Nucl Med. 1998;39:1521–30.
CAS
PubMed
Google Scholar
Kim H-G, Park S, Rhee HY, Lee KM, Ryu C-W, Rhee SJ, Lee SY, Wang Y, Jahng G-H. Quantitative susceptibility mapping to evaluate the early stage of Alzheimer's disease. NeuroImage Clin. 2017;16:429–38.
Article
PubMed
PubMed Central
Google Scholar
Kowall NW, Hantraye P, Brouillet E, Beal MF, McKee AC, Ferrante RJ. MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons. Neuroreport. 2000;11:211–3.
Article
CAS
PubMed
Google Scholar
Ladd ME, Bachert P, Meyerspeer M, Moser E, Nagel AM, Norris DG, Schmitter S, Speck O, Straub S, Zaiss M. Pros and cons of ultra-high-field MRI/MRS for human application. Prog Nucl Magn Reson Spectrosc. 2018;109:1–50.
Article
CAS
PubMed
Google Scholar
Langkammer C, Pirpamer L, Seiler S, Deistung A, Schweser F, Franthal S, Homayoon N, Katschnig-Winter P, Koegl-Wallner M, Pendl T. Quantitative susceptibility mapping in Parkinson’s disease. PLoS One. 2016;11:e0162460.
Article
PubMed
PubMed Central
CAS
Google Scholar
Lee SH, Kim SS, Tae WS, Lee SY, Choi JW, Koh SB, Kwon DY. Regional volume analysis of the Parkinson disease brain in early disease stage: gray matter, white matter, striatum, and thalamus. AJNR Am J Neuroradiol. 2011;32:682–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lehéricy S, Bardinet E, Poupon C, Vidailhet M, François C. 7 tesla magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson’s disease. Move Disord. 2014;29:1574–81.
Article
CAS
Google Scholar
Li DT, Hui ES, Chan Q, Yao N, Chua S, McAlonan GM, Pang SY, Ho S, Mak HK. Quantitative susceptibility mapping as an indicator of subcortical and limbic iron abnormality in Parkinson’s disease with dementia. NeuroImage Clin. 2018;20:365–73.
Article
PubMed
PubMed Central
Google Scholar
Li K, Reichmann H. Role of iron in neurodegenerative diseases. J Neural Transm (Vienna). 2016;123:389–99.
Article
CAS
Google Scholar
Liu C, Wei H, Gong NJ, Cronin M, Dibb R, Decker K. Quantitative susceptibility mapping: contrast mechanisms and clinical applications. Tomography. 2015;1:3–17.
Article
PubMed
PubMed Central
Google Scholar
Liu Z, Spincemaille P, Yao Y, Zhang Y, Wang Y. MEDI+0: morphology enabled dipole inversion with automatic uniform cerebrospinal fluid zero reference for quantitative susceptibility mapping. Magn Reson Med. 2018;79:2795–803.
Article
PubMed
Google Scholar
Logan J, Fowler JS, Volkow ND, Wang G-J, Ding Y-S, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab. 1996;16:834–40.
Article
CAS
PubMed
Google Scholar
Magrinelli F, Picelli A, Tocco P, Federico A, Roncari L, Smania N, Zanette G, Tamburin S. Pathophysiology of motor dysfunction in Parkinson’s disease as the rationale for drug treatment and rehabilitation. Parkinsons Dis. 2016;2016:9832839. https://doi.org/10.1155/2016/9832839.
Article
CAS
Google Scholar
McKeown MJ, Uthama A, Abugharbieh R, Palmer S, Lewis M, Huang X. Shape (but not volume) changes in the thalami in Parkinson disease. BMC Meurol. 2008;8:8.
Article
Google Scholar
McKiernan EF, O'Brien JT. 7T MRI for neurodegenerative dementias in vivo: a systematic review of the literature. J Neurol Neurosurg Psychiatry. 2017;88:564–74.
Article
PubMed
Google Scholar
Murakami Y, Kakeda S, Watanabe K, Ueda I, Ogasawara A, Moriya J, Ide S, Futatsuya K, Sato T, Okada K, Uozumi T, Tsuji S, Liu T, Wang Y, Korogi Y. Usefulness of quantitative susceptibility mapping for the diagnosis of Parkinson disease. AJNR Am J Neuroradiol. 2015;36:1102–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Parker PR, Lalive AL, Kreitzer AC. Pathway-specific remodeling of thalamostriatal synapses in Parkinsonian mice. Neuron. 2016;89:734–40.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pfefferbaum A, Adalsteinsson E, Rohlfing T, Sullivan EV. MRI estimates of brain iron concentration in normal aging: comparison of field-dependent (FDRI) and phase (SWI) methods. Neuroimage. 2009;47:493–500.
Article
PubMed
Google Scholar
Pietracupa S, Martin-Bastida A, Piccini P. Iron metabolism and its detection through MRI in parkinsonian disorders: a systematic review. Neurol Sci. 2017;38:2095–101.
Article
PubMed
Google Scholar
Rohlfing T, Kroenke CD, Sullivan EV, Dubach MF, Bowden DM, Grant K, Pfefferbaum A. The INIA19 template and NeuroMaps atlas for primate brain image parcellation and spatial normalization. Front Neuroinformat. 2012;6:27.
Google Scholar
Schober A. Classic toxin-induced animal models of Parkinson’s disease: 6-OHDA and MPTP. Cell Tissue Res. 2004;318:215–24.
Article
PubMed
Google Scholar
Seo J, Lee Y, Kim BS, Park J, Yang S, Yoon H-J, Yoo J, Park HS, Hong J-J, Koo B-S. A non-human primate model for stable chronic Parkinson’s disease induced by MPTP administration based on individual behavioral quantification. J Neurosci Methods. 2019;311:277–87.
Article
CAS
PubMed
Google Scholar
Shahmaei V, Faeghi F, Mohammdbeigi A, Hashemi H, Ashrafi F. Evaluation of iron deposition in brain basal ganglia of patients with Parkinson's disease using quantitative susceptibility mapping. Eur J Radiol Open. 2019;6:169–74.
Article
PubMed
PubMed Central
Google Scholar
Smith Y, Galvan A, Ellender TJ, Doig N, Villalba RM, Huerta-Ocampo I, Wichmann T, Bolam JP. The thalamostriatal system in normal and diseased states. Front Syst Neurosci. 2014;8:5.
PubMed
PubMed Central
Google Scholar
van der Zwaag W, Schafer A, Marques JP, Turner R, Trampel R. Recent applications of UHF-MRI in the study of human brain function and structure: a review. NMR Biomed. 2016;29:1274–88.
Article
PubMed
Google Scholar
Villalba RM, Wichmann T, Smith Y. Neuronal loss in the caudal intralaminar thalamic nuclei in a primate model of Parkinson's disease. Brain Struct Funct. 2014;219:381–94.
Article
CAS
PubMed
Google Scholar
Wang Y, Liu T. Quantitative susceptibility mapping (QSM): decoding MRI data for a tissue magnetic biomarker. Magn Reson Med. 2015;73:82–101.
Article
CAS
PubMed
Google Scholar
Xu H, Wang Y, Song N, Wang J, Jiang H, Xie J. New progress on the role of glia in iron metabolism and iron-induced degeneration of dopamine neurons in Parkinson’s disease. Front Mol Neurosci. 2017;10:455.
Article
PubMed
CAS
Google Scholar
You LH, Li F, Wang L, Zhao SE, Wang SM, Zhang LL, Zhang LH, Duan XL, Yu P, Chang YZ. Brain iron accumulation exacerbates the pathogenesis of MPTP-induced Parkinson’s disease. Neuroscience. 2015;284:234–46.
Article
CAS
PubMed
Google Scholar
Zhao X, An H, Liu T, Shen N, Bo B, Zhang Z, Weng P, Chen M, Pei M, Wang Y. Quantitative susceptibility mapping of the substantia nigra in Parkinson’s disease. Appl Magn Reson. 2017;48:533–44.
Article
Google Scholar